Agilis Robotics announces completed USD 6 million Series A
Agilis Robotics announced that it had completed a USD 6 million Series A financing round.
Evidence notes
- The company described the financing as its completed A round.
- Agilis was separately preparing a planned USD 5 million Pre-B round, which is not counted as completed capital here.
- The company intended to use new financing to support FDA and NMPA regulatory work for its surgical robot.
Company context
Agilis Robotics develops miniature flexible robotic instruments for endoluminal surgery. The platform is designed to navigate natural anatomical pathways and give surgeons dexterous control in procedures where conventional rigid instruments have limited reach.